0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neurovascular Thrombectomy Device Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-3N7442
Home | Market Reports | Health| Medical Devices & Equipment
Global Neurovascular Thrombectomy Device Market Insights Forecast to 2028
BUY CHAPTERS

Global Neurovascular Thrombectomy Device Market Research Report 2025

Code: QYRE-Auto-3N7442
Report
August 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Neurovascular Thrombectomy Device Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Neurovascular Thrombectomy Device Market

Neurovascular Thrombectomy Device Market

The global market for Neurovascular Thrombectomy Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Neurovascular Thrombectomy Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurovascular Thrombectomy Device.
The Neurovascular Thrombectomy Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neurovascular Thrombectomy Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurovascular Thrombectomy Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Neurovascular Thrombectomy Device Market Report

Report Metric Details
Report Name Neurovascular Thrombectomy Device Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
Segment by Application
  • Hospitals and Surgical Centers
  • Ambulatory Surgical Centers
  • Research Laboratories & Academic Institutes
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Stryker Corporation (U.S.), Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), Teleflex Incorporated (U.S.)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Neurovascular Thrombectomy Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Neurovascular Thrombectomy Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Neurovascular Thrombectomy Device Market report?

Ans: The main players in the Neurovascular Thrombectomy Device Market are Stryker Corporation (U.S.), Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), Teleflex Incorporated (U.S.)

What are the Application segmentation covered in the Neurovascular Thrombectomy Device Market report?

Ans: The Applications covered in the Neurovascular Thrombectomy Device Market report are Hospitals and Surgical Centers, Ambulatory Surgical Centers, Research Laboratories & Academic Institutes, Others

What are the Type segmentation covered in the Neurovascular Thrombectomy Device Market report?

Ans: The Types covered in the Neurovascular Thrombectomy Device Market report are Mechanical/Fragmentation Thrombectomy Devices, Stent Retrievers, Basket/Brush Retrievers, Coil Retrievers, Aspiration Thrombectomy Devices, Rheolytic/Hydrodynamic Thrombectomy Devices, Ultrasonic Thrombectomy Devices

Recommended Reports

Neurovascular Devices

Stroke & Thrombectomy

Neurosurgery Equipment

1 Neurovascular Thrombectomy Device Market Overview
1.1 Product Definition
1.2 Neurovascular Thrombectomy Device by Type
1.2.1 Global Neurovascular Thrombectomy Device Market Value Comparison by Type (2024 VS 2031)
1.2.2 Mechanical/Fragmentation Thrombectomy Devices
1.2.3 Stent Retrievers
1.2.4 Basket/Brush Retrievers
1.2.5 Coil Retrievers
1.2.6 Aspiration Thrombectomy Devices
1.2.7 Rheolytic/Hydrodynamic Thrombectomy Devices
1.2.8 Ultrasonic Thrombectomy Devices
1.3 Neurovascular Thrombectomy Device by Application
1.3.1 Global Neurovascular Thrombectomy Device Market Value by Application (2024 VS 2031)
1.3.2 Hospitals and Surgical Centers
1.3.3 Ambulatory Surgical Centers
1.3.4 Research Laboratories & Academic Institutes
1.3.5 Others
1.4 Global Neurovascular Thrombectomy Device Market Size Estimates and Forecasts
1.4.1 Global Neurovascular Thrombectomy Device Revenue 2020-2031
1.4.2 Global Neurovascular Thrombectomy Device Sales 2020-2031
1.4.3 Global Neurovascular Thrombectomy Device Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Neurovascular Thrombectomy Device Market Competition by Manufacturers
2.1 Global Neurovascular Thrombectomy Device Sales Market Share by Manufacturers (2020-2025)
2.2 Global Neurovascular Thrombectomy Device Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Neurovascular Thrombectomy Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Neurovascular Thrombectomy Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neurovascular Thrombectomy Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurovascular Thrombectomy Device, Product Type & Application
2.7 Global Key Manufacturers of Neurovascular Thrombectomy Device, Date of Enter into This Industry
2.8 Global Neurovascular Thrombectomy Device Market Competitive Situation and Trends
2.8.1 Global Neurovascular Thrombectomy Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Neurovascular Thrombectomy Device Players Market Share by Revenue
2.8.3 Global Neurovascular Thrombectomy Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Neurovascular Thrombectomy Device Market Scenario by Region
3.1 Global Neurovascular Thrombectomy Device Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Neurovascular Thrombectomy Device Sales by Region: 2020-2031
3.2.1 Global Neurovascular Thrombectomy Device Sales by Region: 2020-2025
3.2.2 Global Neurovascular Thrombectomy Device Sales by Region: 2026-2031
3.3 Global Neurovascular Thrombectomy Device Revenue by Region: 2020-2031
3.3.1 Global Neurovascular Thrombectomy Device Revenue by Region: 2020-2025
3.3.2 Global Neurovascular Thrombectomy Device Revenue by Region: 2026-2031
3.4 North America Neurovascular Thrombectomy Device Market Facts & Figures by Country
3.4.1 North America Neurovascular Thrombectomy Device Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Neurovascular Thrombectomy Device Sales by Country (2020-2031)
3.4.3 North America Neurovascular Thrombectomy Device Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neurovascular Thrombectomy Device Market Facts & Figures by Country
3.5.1 Europe Neurovascular Thrombectomy Device Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Neurovascular Thrombectomy Device Sales by Country (2020-2031)
3.5.3 Europe Neurovascular Thrombectomy Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurovascular Thrombectomy Device Market Facts & Figures by Region
3.6.1 Asia Pacific Neurovascular Thrombectomy Device Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Neurovascular Thrombectomy Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Neurovascular Thrombectomy Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Neurovascular Thrombectomy Device Market Facts & Figures by Country
3.7.1 Latin America Neurovascular Thrombectomy Device Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Neurovascular Thrombectomy Device Sales by Country (2020-2031)
3.7.3 Latin America Neurovascular Thrombectomy Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neurovascular Thrombectomy Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurovascular Thrombectomy Device Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Neurovascular Thrombectomy Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Neurovascular Thrombectomy Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neurovascular Thrombectomy Device Sales by Type (2020-2031)
4.1.1 Global Neurovascular Thrombectomy Device Sales by Type (2020-2025)
4.1.2 Global Neurovascular Thrombectomy Device Sales by Type (2026-2031)
4.1.3 Global Neurovascular Thrombectomy Device Sales Market Share by Type (2020-2031)
4.2 Global Neurovascular Thrombectomy Device Revenue by Type (2020-2031)
4.2.1 Global Neurovascular Thrombectomy Device Revenue by Type (2020-2025)
4.2.2 Global Neurovascular Thrombectomy Device Revenue by Type (2026-2031)
4.2.3 Global Neurovascular Thrombectomy Device Revenue Market Share by Type (2020-2031)
4.3 Global Neurovascular Thrombectomy Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Neurovascular Thrombectomy Device Sales by Application (2020-2031)
5.1.1 Global Neurovascular Thrombectomy Device Sales by Application (2020-2025)
5.1.2 Global Neurovascular Thrombectomy Device Sales by Application (2026-2031)
5.1.3 Global Neurovascular Thrombectomy Device Sales Market Share by Application (2020-2031)
5.2 Global Neurovascular Thrombectomy Device Revenue by Application (2020-2031)
5.2.1 Global Neurovascular Thrombectomy Device Revenue by Application (2020-2025)
5.2.2 Global Neurovascular Thrombectomy Device Revenue by Application (2026-2031)
5.2.3 Global Neurovascular Thrombectomy Device Revenue Market Share by Application (2020-2031)
5.3 Global Neurovascular Thrombectomy Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Stryker Corporation (U.S.)
6.1.1 Stryker Corporation (U.S.) Company Information
6.1.2 Stryker Corporation (U.S.) Description and Business Overview
6.1.3 Stryker Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Stryker Corporation (U.S.) Neurovascular Thrombectomy Device Product Portfolio
6.1.5 Stryker Corporation (U.S.) Recent Developments/Updates
6.2 Medtronic plc (Ireland)
6.2.1 Medtronic plc (Ireland) Company Information
6.2.2 Medtronic plc (Ireland) Description and Business Overview
6.2.3 Medtronic plc (Ireland) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Medtronic plc (Ireland) Neurovascular Thrombectomy Device Product Portfolio
6.2.5 Medtronic plc (Ireland) Recent Developments/Updates
6.3 Boston Scientific Corporation (U.S.)
6.3.1 Boston Scientific Corporation (U.S.) Company Information
6.3.2 Boston Scientific Corporation (U.S.) Description and Business Overview
6.3.3 Boston Scientific Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boston Scientific Corporation (U.S.) Neurovascular Thrombectomy Device Product Portfolio
6.3.5 Boston Scientific Corporation (U.S.) Recent Developments/Updates
6.4 Johnson & Johnson (U.S.)
6.4.1 Johnson & Johnson (U.S.) Company Information
6.4.2 Johnson & Johnson (U.S.) Description and Business Overview
6.4.3 Johnson & Johnson (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Johnson & Johnson (U.S.) Neurovascular Thrombectomy Device Product Portfolio
6.4.5 Johnson & Johnson (U.S.) Recent Developments/Updates
6.5 Terumo Corporation (Japan)
6.5.1 Terumo Corporation (Japan) Company Information
6.5.2 Terumo Corporation (Japan) Description and Business Overview
6.5.3 Terumo Corporation (Japan) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Terumo Corporation (Japan) Neurovascular Thrombectomy Device Product Portfolio
6.5.5 Terumo Corporation (Japan) Recent Developments/Updates
6.6 Penumbra, Inc. (U.S.)
6.6.1 Penumbra, Inc. (U.S.) Company Information
6.6.2 Penumbra, Inc. (U.S.) Description and Business Overview
6.6.3 Penumbra, Inc. (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Penumbra, Inc. (U.S.) Neurovascular Thrombectomy Device Product Portfolio
6.6.5 Penumbra, Inc. (U.S.) Recent Developments/Updates
6.7 Spectranetics Corporation (U.S.)
6.7.1 Spectranetics Corporation (U.S.) Company Information
6.7.2 Spectranetics Corporation (U.S.) Description and Business Overview
6.7.3 Spectranetics Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Spectranetics Corporation (U.S.) Neurovascular Thrombectomy Device Product Portfolio
6.7.5 Spectranetics Corporation (U.S.) Recent Developments/Updates
6.8 Edwards Lifesciences Corporation (U.S.)
6.8.1 Edwards Lifesciences Corporation (U.S.) Company Information
6.8.2 Edwards Lifesciences Corporation (U.S.) Description and Business Overview
6.8.3 Edwards Lifesciences Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Edwards Lifesciences Corporation (U.S.) Neurovascular Thrombectomy Device Product Portfolio
6.8.5 Edwards Lifesciences Corporation (U.S.) Recent Developments/Updates
6.9 Argon Medical Devices, Inc. (U.S.)
6.9.1 Argon Medical Devices, Inc. (U.S.) Company Information
6.9.2 Argon Medical Devices, Inc. (U.S.) Description and Business Overview
6.9.3 Argon Medical Devices, Inc. (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Argon Medical Devices, Inc. (U.S.) Neurovascular Thrombectomy Device Product Portfolio
6.9.5 Argon Medical Devices, Inc. (U.S.) Recent Developments/Updates
6.10 Teleflex Incorporated (U.S.)
6.10.1 Teleflex Incorporated (U.S.) Company Information
6.10.2 Teleflex Incorporated (U.S.) Description and Business Overview
6.10.3 Teleflex Incorporated (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Teleflex Incorporated (U.S.) Neurovascular Thrombectomy Device Product Portfolio
6.10.5 Teleflex Incorporated (U.S.) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurovascular Thrombectomy Device Industry Chain Analysis
7.2 Neurovascular Thrombectomy Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurovascular Thrombectomy Device Production Mode & Process Analysis
7.4 Neurovascular Thrombectomy Device Sales and Marketing
7.4.1 Neurovascular Thrombectomy Device Sales Channels
7.4.2 Neurovascular Thrombectomy Device Distributors
7.5 Neurovascular Thrombectomy Device Customer Analysis
8 Neurovascular Thrombectomy Device Market Dynamics
8.1 Neurovascular Thrombectomy Device Industry Trends
8.2 Neurovascular Thrombectomy Device Market Drivers
8.3 Neurovascular Thrombectomy Device Market Challenges
8.4 Neurovascular Thrombectomy Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Neurovascular Thrombectomy Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Neurovascular Thrombectomy Device Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Neurovascular Thrombectomy Device Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Neurovascular Thrombectomy Device Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Neurovascular Thrombectomy Device Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Neurovascular Thrombectomy Device Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Neurovascular Thrombectomy Device Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Neurovascular Thrombectomy Device Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Neurovascular Thrombectomy Device, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Neurovascular Thrombectomy Device, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Neurovascular Thrombectomy Device, Product Type & Application
 Table 12. Global Key Manufacturers of Neurovascular Thrombectomy Device, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Neurovascular Thrombectomy Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurovascular Thrombectomy Device as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Neurovascular Thrombectomy Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Neurovascular Thrombectomy Device Sales by Region (2020-2025) & (K Units)
 Table 18. Global Neurovascular Thrombectomy Device Sales Market Share by Region (2020-2025)
 Table 19. Global Neurovascular Thrombectomy Device Sales by Region (2026-2031) & (K Units)
 Table 20. Global Neurovascular Thrombectomy Device Sales Market Share by Region (2026-2031)
 Table 21. Global Neurovascular Thrombectomy Device Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Neurovascular Thrombectomy Device Revenue Market Share by Region (2020-2025)
 Table 23. Global Neurovascular Thrombectomy Device Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Neurovascular Thrombectomy Device Revenue Market Share by Region (2026-2031)
 Table 25. North America Neurovascular Thrombectomy Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Neurovascular Thrombectomy Device Sales by Country (2020-2025) & (K Units)
 Table 27. North America Neurovascular Thrombectomy Device Sales by Country (2026-2031) & (K Units)
 Table 28. North America Neurovascular Thrombectomy Device Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Neurovascular Thrombectomy Device Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Neurovascular Thrombectomy Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Neurovascular Thrombectomy Device Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Neurovascular Thrombectomy Device Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Neurovascular Thrombectomy Device Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Neurovascular Thrombectomy Device Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Neurovascular Thrombectomy Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Neurovascular Thrombectomy Device Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Neurovascular Thrombectomy Device Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Neurovascular Thrombectomy Device Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Neurovascular Thrombectomy Device Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Neurovascular Thrombectomy Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Neurovascular Thrombectomy Device Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Neurovascular Thrombectomy Device Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Neurovascular Thrombectomy Device Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Neurovascular Thrombectomy Device Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Neurovascular Thrombectomy Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Neurovascular Thrombectomy Device Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Neurovascular Thrombectomy Device Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Neurovascular Thrombectomy Device Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Neurovascular Thrombectomy Device Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Neurovascular Thrombectomy Device Sales (K Units) by Type (2020-2025)
 Table 51. Global Neurovascular Thrombectomy Device Sales (K Units) by Type (2026-2031)
 Table 52. Global Neurovascular Thrombectomy Device Sales Market Share by Type (2020-2025)
 Table 53. Global Neurovascular Thrombectomy Device Sales Market Share by Type (2026-2031)
 Table 54. Global Neurovascular Thrombectomy Device Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Neurovascular Thrombectomy Device Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Neurovascular Thrombectomy Device Revenue Market Share by Type (2020-2025)
 Table 57. Global Neurovascular Thrombectomy Device Revenue Market Share by Type (2026-2031)
 Table 58. Global Neurovascular Thrombectomy Device Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Neurovascular Thrombectomy Device Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Neurovascular Thrombectomy Device Sales (K Units) by Application (2020-2025)
 Table 61. Global Neurovascular Thrombectomy Device Sales (K Units) by Application (2026-2031)
 Table 62. Global Neurovascular Thrombectomy Device Sales Market Share by Application (2020-2025)
 Table 63. Global Neurovascular Thrombectomy Device Sales Market Share by Application (2026-2031)
 Table 64. Global Neurovascular Thrombectomy Device Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Neurovascular Thrombectomy Device Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Neurovascular Thrombectomy Device Revenue Market Share by Application (2020-2025)
 Table 67. Global Neurovascular Thrombectomy Device Revenue Market Share by Application (2026-2031)
 Table 68. Global Neurovascular Thrombectomy Device Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Neurovascular Thrombectomy Device Price (USD/Unit) by Application (2026-2031)
 Table 70. Stryker Corporation (U.S.) Company Information
 Table 71. Stryker Corporation (U.S.) Description and Business Overview
 Table 72. Stryker Corporation (U.S.) Neurovascular Thrombectomy Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Stryker Corporation (U.S.) Neurovascular Thrombectomy Device Product
 Table 74. Stryker Corporation (U.S.) Recent Developments/Updates
 Table 75. Medtronic plc (Ireland) Company Information
 Table 76. Medtronic plc (Ireland) Description and Business Overview
 Table 77. Medtronic plc (Ireland) Neurovascular Thrombectomy Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Medtronic plc (Ireland) Neurovascular Thrombectomy Device Product
 Table 79. Medtronic plc (Ireland) Recent Developments/Updates
 Table 80. Boston Scientific Corporation (U.S.) Company Information
 Table 81. Boston Scientific Corporation (U.S.) Description and Business Overview
 Table 82. Boston Scientific Corporation (U.S.) Neurovascular Thrombectomy Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Boston Scientific Corporation (U.S.) Neurovascular Thrombectomy Device Product
 Table 84. Boston Scientific Corporation (U.S.) Recent Developments/Updates
 Table 85. Johnson & Johnson (U.S.) Company Information
 Table 86. Johnson & Johnson (U.S.) Description and Business Overview
 Table 87. Johnson & Johnson (U.S.) Neurovascular Thrombectomy Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Johnson & Johnson (U.S.) Neurovascular Thrombectomy Device Product
 Table 89. Johnson & Johnson (U.S.) Recent Developments/Updates
 Table 90. Terumo Corporation (Japan) Company Information
 Table 91. Terumo Corporation (Japan) Description and Business Overview
 Table 92. Terumo Corporation (Japan) Neurovascular Thrombectomy Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Terumo Corporation (Japan) Neurovascular Thrombectomy Device Product
 Table 94. Terumo Corporation (Japan) Recent Developments/Updates
 Table 95. Penumbra, Inc. (U.S.) Company Information
 Table 96. Penumbra, Inc. (U.S.) Description and Business Overview
 Table 97. Penumbra, Inc. (U.S.) Neurovascular Thrombectomy Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Penumbra, Inc. (U.S.) Neurovascular Thrombectomy Device Product
 Table 99. Penumbra, Inc. (U.S.) Recent Developments/Updates
 Table 100. Spectranetics Corporation (U.S.) Company Information
 Table 101. Spectranetics Corporation (U.S.) Description and Business Overview
 Table 102. Spectranetics Corporation (U.S.) Neurovascular Thrombectomy Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Spectranetics Corporation (U.S.) Neurovascular Thrombectomy Device Product
 Table 104. Spectranetics Corporation (U.S.) Recent Developments/Updates
 Table 105. Edwards Lifesciences Corporation (U.S.) Company Information
 Table 106. Edwards Lifesciences Corporation (U.S.) Description and Business Overview
 Table 107. Edwards Lifesciences Corporation (U.S.) Neurovascular Thrombectomy Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Edwards Lifesciences Corporation (U.S.) Neurovascular Thrombectomy Device Product
 Table 109. Edwards Lifesciences Corporation (U.S.) Recent Developments/Updates
 Table 110. Argon Medical Devices, Inc. (U.S.) Company Information
 Table 111. Argon Medical Devices, Inc. (U.S.) Description and Business Overview
 Table 112. Argon Medical Devices, Inc. (U.S.) Neurovascular Thrombectomy Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Argon Medical Devices, Inc. (U.S.) Neurovascular Thrombectomy Device Product
 Table 114. Argon Medical Devices, Inc. (U.S.) Recent Developments/Updates
 Table 115. Teleflex Incorporated (U.S.) Company Information
 Table 116. Teleflex Incorporated (U.S.) Description and Business Overview
 Table 117. Teleflex Incorporated (U.S.) Neurovascular Thrombectomy Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Teleflex Incorporated (U.S.) Neurovascular Thrombectomy Device Product
 Table 119. Teleflex Incorporated (U.S.) Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Neurovascular Thrombectomy Device Distributors List
 Table 123. Neurovascular Thrombectomy Device Customers List
 Table 124. Neurovascular Thrombectomy Device Market Trends
 Table 125. Neurovascular Thrombectomy Device Market Drivers
 Table 126. Neurovascular Thrombectomy Device Market Challenges
 Table 127. Neurovascular Thrombectomy Device Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Neurovascular Thrombectomy Device
 Figure 2. Global Neurovascular Thrombectomy Device Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Neurovascular Thrombectomy Device Market Share by Type: 2024 & 2031
 Figure 4. Mechanical/Fragmentation Thrombectomy Devices Product Picture
 Figure 5. Stent Retrievers Product Picture
 Figure 6. Basket/Brush Retrievers Product Picture
 Figure 7. Coil Retrievers Product Picture
 Figure 8. Aspiration Thrombectomy Devices Product Picture
 Figure 9. Rheolytic/Hydrodynamic Thrombectomy Devices Product Picture
 Figure 10. Ultrasonic Thrombectomy Devices Product Picture
 Figure 11. Global Neurovascular Thrombectomy Device Market Value by Application (2020-2031) & (US$ Million)
 Figure 12. Global Neurovascular Thrombectomy Device Market Share by Application: 2024 & 2031
 Figure 13. Hospitals and Surgical Centers
 Figure 14. Ambulatory Surgical Centers
 Figure 15. Research Laboratories & Academic Institutes
 Figure 16. Others
 Figure 17. Global Neurovascular Thrombectomy Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Neurovascular Thrombectomy Device Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Neurovascular Thrombectomy Device Sales (2020-2031) & (K Units)
 Figure 20. Global Neurovascular Thrombectomy Device Average Price (USD/Unit) & (2020-2031)
 Figure 21. Neurovascular Thrombectomy Device Report Years Considered
 Figure 22. Neurovascular Thrombectomy Device Sales Share by Manufacturers in 2024
 Figure 23. Global Neurovascular Thrombectomy Device Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Neurovascular Thrombectomy Device Players: Market Share by Revenue in Neurovascular Thrombectomy Device in 2024
 Figure 25. Neurovascular Thrombectomy Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Neurovascular Thrombectomy Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Neurovascular Thrombectomy Device Sales Market Share by Country (2020-2031)
 Figure 28. North America Neurovascular Thrombectomy Device Revenue Market Share by Country (2020-2031)
 Figure 29. U.S. Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Neurovascular Thrombectomy Device Sales Market Share by Country (2020-2031)
 Figure 32. Europe Neurovascular Thrombectomy Device Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Neurovascular Thrombectomy Device Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Neurovascular Thrombectomy Device Revenue Market Share by Region (2020-2031)
 Figure 40. China Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Taiwan Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Philippines Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Neurovascular Thrombectomy Device Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Neurovascular Thrombectomy Device Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Neurovascular Thrombectomy Device Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Neurovascular Thrombectomy Device Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. UAE Neurovascular Thrombectomy Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Neurovascular Thrombectomy Device by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Neurovascular Thrombectomy Device by Type (2020-2031)
 Figure 62. Global Neurovascular Thrombectomy Device Price (USD/Unit) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Neurovascular Thrombectomy Device by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Neurovascular Thrombectomy Device by Application (2020-2031)
 Figure 65. Global Neurovascular Thrombectomy Device Price (USD/Unit) by Application (2020-2031)
 Figure 66. Neurovascular Thrombectomy Device Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart